BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 15684051)

  • 1. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.
    Smith KR; Pinkerton KE; Watanabe T; Pedersen TL; Ma SJ; Hammock BD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2186-91. PubMed ID: 15684051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.
    Davis BB; Liu JY; Tancredi DJ; Wang L; Simon SI; Hammock BD; Pinkerton KE
    Biochem Biophys Res Commun; 2011 Jul; 410(3):494-500. PubMed ID: 21683067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor.
    Podolin PL; Bolognese BJ; Foley JF; Long E; Peck B; Umbrecht S; Zhang X; Zhu P; Schwartz B; Xie W; Quinn C; Qi H; Sweitzer S; Chen S; Galop M; Ding Y; Belyanskaya SL; Israel DI; Morgan BA; Behm DJ; Marino JP; Kurali E; Barnette MS; Mayer RJ; Booth-Genthe CL; Callahan JF
    Prostaglandins Other Lipid Mediat; 2013; 104-105():25-31. PubMed ID: 23434473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
    Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of soluble epoxide hydrolase (sEH) activity.
    Morisseau C; Hammock BD
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.
    Wang L; Yang J; Guo L; Uyeminami D; Dong H; Hammock BD; Pinkerton KE
    Am J Respir Cell Mol Biol; 2012 May; 46(5):614-22. PubMed ID: 22180869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute tobacco smoke-induced airways inflammation in spontaneously hypertensive rats.
    Yu B; Kodavanti UP; Takeuchi M; Witschi H; Pinkerton KE
    Inhal Toxicol; 2008 May; 20(7):623-33. PubMed ID: 18464051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
    Revermann M; Schloss M; Barbosa-Sicard E; Mieth A; Liebner S; Morisseau C; Geisslinger G; Schermuly RT; Fleming I; Hammock BD; Brandes RP
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The weakening effect of soluble epoxide hydrolase inhibitor AUDA on febrile response to lipopolysaccharide and turpentine in rat.
    Piotrowski J; Jędrzejewski T; Pawlikowska M; Pacuła AJ; Ścianowski J; Kozak W
    J Physiol Biochem; 2017 Nov; 73(4):551-560. PubMed ID: 28741242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
    Jiang JX; Guan Y; Shen HJ; Jia YL; Shen J; Zhang LH; Liu Q; Zhu YL; Xie QM
    Eur J Pharmacol; 2020 Feb; 868():172874. PubMed ID: 31866410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.
    Inceoglu B; Jinks SL; Schmelzer KR; Waite T; Kim IH; Hammock BD
    Life Sci; 2006 Nov; 79(24):2311-9. PubMed ID: 16962614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
    Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
    J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
    Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
    J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting epoxides for organ damage in hypertension.
    Imig JD
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):329-35. PubMed ID: 20531214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.